Things became litigious in 2017, when a Delaware court found that Teva's label for its generic encouraged doctors to use the drug to treat heart failure in a way that infringed GSK's RE40,000 ...

If confirmed, GSK could discuss the data with regulators in hopes of securing an expanded label for the jab. More than 55 million people globally have dementia. For decades the field of Alzheimer ...

GSK plc GSK announced that the European Commission ... Sales of the drug are being driven by new patient starts in the United States. Some label expansion studies are ongoing on Jemperli, either ...

Pfizer (NYSE:PFE) and GSK (NYSE:GSK) are expected to reap benefits ... has sought U.S. approval to expand the label of its RSV shot, mRESVIA, to those aged 18-59 after the FDA cleared the ...